LEADER 03486nam 22006495 450 001 9910491025503321 005 20260213123645.0 010 $a3-030-77111-3 024 7 $a10.1007/978-3-030-77111-9 035 $a(CKB)4100000011979479 035 $a(MiAaPQ)EBC6676432 035 $a(Au-PeEL)EBL6676432 035 $a(OCoLC)1260346772 035 $a(DE-He213)978-3-030-77111-9 035 $a(PPN)269145990 035 $a(EXLCZ)994100000011979479 100 $a20210707d2021 u| 0 101 0 $aeng 135 $aurcnu|||||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aControversies in Testosterone Deficiency /$fedited by John P. Mulhall, Mario Maggi, Landon Trost 205 $a1st ed. 2021. 210 1$aCham :$cSpringer International Publishing :$cImprint: Springer,$d2021. 215 $a1 online resource (143 pages) 311 08$a3-030-77110-5 327 $aWhat to Measure: Testosterone or Free Testosterone? -- Erythrocytosis in Patients on Testosterone Therapy -- Role of Gonadotropins in Adult-Onset Functional Hypogonadism -- Hyperprolactinemia in the Man with Testosterone Deficiency -- Testosterone and Disordered Sleep -- Testosterone Therapy and Male Fertility -- Testosterone and Prostate Effects -- Testosterone in Females -- Testosterone in Transgender Population -- Testosterone as a Performance Enhancer. 330 $aThis book aims to address a number of controversies concerning the use of testosterone treatment. It explains topics that clinicians regularly encounter such as whether to use free or total testosterone in the evaluation of the patient with testosterone deficiency; what factors actually impact testosterone levels, polycythemia, gynecomastia, bone density, and hyperprolactinemia in the testosterone deficient patient; critical analysis of the numerous questionnaires that are available to clinicians; and the impact of testosterone therapy on male fertility, cardiovascular disease, and prostate events including prostate cancer. Guiding the reader in both evaluation and management, the book also illuminates novel concepts in the T space such as testosterone use in the transgender population, T therapy as an endothelial modulator, bipolar testosterone therapy in the patient with advanced prostate cancer, and testosterone therapy as a performance enhancer. Controversiesin Testosterone Deficiency is intended for any clinician involved in the care of patients with testosterone deficiency, exploring hot topics and correcting existent misinformation in the routine care of patients. 606 $aUrology 606 $aEndocrinology 606 $aReproductive health 606 $aUrology 606 $aEndocrinology 606 $aReproductive Medicine 606 $aTestosterona$2thub 606 $aEfectes fisiològics$2thub 608 $aLlibres electrònics$2thub 615 0$aUrology. 615 0$aEndocrinology. 615 0$aReproductive health. 615 14$aUrology. 615 24$aEndocrinology. 615 24$aReproductive Medicine. 615 7$aTestosterona 615 7$aEfectes fisiològics 676 $a612.61 700 $aMulhall$b John P.$0755391 702 $aMaggi$b M. 702 $aTrost$b Landon 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910491025503321 996 $aControversies in testosterone deficiency$92819196 997 $aUNINA